Related Experiment Video
Updated: Oct 6, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Demand with low supply: A pipeline for personalized integrative medicine in multiple sclerosis
Heena R Manglani1, Brian C Healy2, Ana-Maria Vranceanu1
1Integrated Brain Health Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Abstract:
Timely personalized medicine is an unmet, critical need in multiple sclerosis (MS). A major barrier to providing individualized care is the lack of information on which interventions are most appropriate for whom. In this viewpoint, we submit a rationale and three-step roadmap to personalized integrative medicine. This multidisciplinary team approach requires that we (1) comprehensively assess whole health at diagnosis, (2) appropriately integrate data within electronic health record systems and leverage machine learning to analyze big data, and (3) design, test, and deliver multimodal interventions. Using a whole-person approach to assessment and intervention, we will be better informed to provide personalized care at the level of the individual.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Products: Biologics, Biosimilars and Interchangeables
Mesenchymal Stem Cells
Microorganisms in Medicine and Therapeutics

